STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

被引：0
|
作者：
Cosimo Lobello
Boris Tichy
Vojtech Bystry
Lenka Radova
Daniel Filip
Marek Mraz
Ivonne-Aidee Montes-Mojarro
Nina Prokoph
Hugo Larose
Huan-Chang Liang
Geeta G. Sharma
Luca Mologni
David Belada
Katerina Kamaradova
Falko Fend
Carlo Gambacorti-Passerini
Olaf Merkel
Suzanne D. Turner
Andrea Janikova
Sarka Pospisilova
机构：
[1] Masaryk University,Center of Molecular Medicine, Central European Institute of Technology (CEITEC)
[2] University Hospital Brno and Medical Faculty MU,Department of Internal Medicine—Hematology and Oncology
[3] Eberhard Karls University,Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen
[4] University of Cambridge,Division of Cellular and Molecular Pathology, Department of Pathology
[5] Medical University of Vienna,Department of Pathology
[6] University of Milano-Bicocca,Department of Medicine and Surgery
[7] Charles University Hospital and Faculty of Medicine,4th Department of Internal Medicine—Hematology
[8] Charles University Hospital and Faculty of Medicine,Fingerland Department of Pathology
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1500 / 1505
页数：5
相关论文
共 50 条
  • [1] STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
    Lobello, Cosimo
    Tichy, Boris
    Bystry, Vojtech
    Radova, Lenka
    Filip, Daniel
    Mraz, Marek
    Montes-Mojarro, Ivonne-Aidee
    Prokoph, Nina
    Larose, Hugo
    Liang, Huan-Chang
    Sharma, Geeta G.
    Mologni, Luca
    Belada, David
    Kamaradova, Katerina
    Fend, Falko
    Gambacorti-Passerini, Carlo
    Merkel, Olaf
    Turner, Suzanne D.
    Janikova, Andrea
    Pospisilova, Sarka
    LEUKEMIA, 2021, 35 (05) : 1500 - 1505
  • [2] Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
    Crescenzo, Ramona
    Abate, Francesco
    Lasorsa, Elena
    Tabbo', Fabrizio
    Gaudiano, Marcello
    Chiesa, Nicoletta
    Di Giacomo, Filomena
    Spaccarotella, Elisa
    Barbarossa, Luigi
    Ercole, Elisabetta
    Todaro, Maria
    Boi, Michela
    Acquaviva, Andrea
    Ficarra, Elisa
    Novero, Domenico
    Rinaldi, Andrea
    Tousseyn, Thomas
    Rosenwald, Andreas
    Kenner, Lukas
    Cerroni, Lorenzo
    Tzankov, Alexander
    Ponzoni, Maurilio
    Paulli, Marco
    Weisenburger, Dennis
    Chan, Wing C.
    Iqbal, Javeed
    Piris, Miguel A.
    Zamo', Alberto
    Ciardullo, Carmela
    Rossi, Davide
    Gaidano, Gianluca
    Pileri, Stefano
    Tiacci, Enrico
    Falini, Brunangelo
    Shultz, Leonard D.
    Mevellec, Laurence
    Vialard, Jorge E.
    Piva, Roberto
    Bertoni, Francesco
    Rabadan, Raul
    Inghirami, Giorgio
    CANCER CELL, 2015, 27 (04) : 516 - 532
  • [3] Pathogenic TP53 mutations Are Associated with a Poor Prognosis in De Novo AML
    Lamble, Adam J.
    Ries, Rhonda E.
    Dang, Alice
    Alonzo, Todd A.
    Chisholm, Karen
    Kolekar, Pandurang
    Liu, Yanling
    Tran, Quang
    Cooper, Todd M.
    Aplenc, Richard
    Gamis, Alan S.
    Kolb, Edward A.
    Ma, Xiaotu
    Meshinchi, Soheil
    BLOOD, 2022, 140 : 6297 - 6298
  • [4] The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis
    Qiu, Lianqun
    Medeiros, L. Jeffrey
    Tang, Guilin
    Khanlari, Mahsa
    Li, Shaoying
    Konoplev, Sergej
    Wang, Sa A.
    Yin, C. Cameron
    Khoury, Joseph D.
    Wang, Wei
    Miranda, Roberto N.
    Iyer, Swaminathan
    You, M. James
    Xu, Jie
    CANCERS, 2021, 13 (24)
  • [5] Prognostic significance of STAT3 activation in systemic anaplastic large cell lymphoma
    Khoury, JD
    Medeiros, LJ
    Rassidakis, GZ
    Tsioli, P
    Leventaki, V
    Schmitt-Graeff, A
    Herling, M
    Sarris, AH
    Lai, R
    LABORATORY INVESTIGATION, 2003, 83 (01) : 239A - 240A
  • [6] Prognostic significance of STAT3 activation in systemic anaplastic large cell lymphoma
    Khoury, JD
    Medeiros, LJ
    Rassidakis, GZ
    Tsioli, P
    Leventaki, V
    Schmitt-Graeff, A
    Herling, M
    Sarris, AH
    Lai, R
    MODERN PATHOLOGY, 2003, 16 (01) : 239A - 240A
  • [7] Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
    Crescenzo, Ramona
    Abate, Francesco
    Lasorsa, Elena
    Tabbo', Fabrizio
    Gaudiano, Marcello
    Chiesa, Nicoletta
    Di Giacomo, Filomena
    Spaccarotella, Elisa
    Barbarossa, Luigi
    Todaro, Maria
    Boi, Michela
    Tousseyn, Thomas
    Rosenwald, Andreas
    Kenner, Lukas
    Rossi, Davide
    Mevellec, Laurence
    Vialard, Jorge
    Bertoni, Francesco
    Rabadan, Raul
    Inghirami, Giorgio
    BLOOD, 2014, 124 (21)
  • [8] Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A
    Di Napoli, Arianna
    Jain, Preti
    Duranti, Enrico
    Margolskee, Elizabeth
    Arancio, Walter
    Facchetti, Fabio
    Alobeid, Bachir
    di Pompeo, Fabio Santanelli
    Mansukhani, Mahesh
    Bhagat, Govind
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (05) : 741 - 744
  • [9] Prognosis and Efficacy Analysis of Diffuse Large B-Cell Lymphoma with TP53 Mutations: A Single-Center Study
    Zhang, Haiyan
    Zhang, Xiang
    Wang, Jinghan
    Zhang, Xuewu
    Lv, Yunfei
    Zhu, Yanan
    Wei, Juying
    Yang, Min
    Xu, Gaixiang
    Ye, Xingnong
    Lou, Yinjun
    Yang, Chunmei
    Meng, Haitao
    Xie, Wanzhuo
    Tong, Hongyan
    Yu, Wenjuan
    BLOOD, 2024, 144 : 6468 - 6469
  • [10] Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
    Blombery, Piers
    Thompson, Ella R.
    Jones, Kate
    Arnau, Gisela Mir
    Lade, Stephen
    Markham, John F.
    Li, Jason
    Deva, Anand
    Johnstone, Ricky W.
    Khot, Amit
    Prince, H. Miles
    Westerman, David
    HAEMATOLOGICA, 2016, 101 (09)
12345